1. Bioleaching of realgar nanoparticles using the extremophilic bacterium Acidithiobacillus ferrooxidans DLC-5
    Ruixiang Xu et al, 2019, Electronic Journal of Biotechnology CrossRef
  2. Development of Realgar Nanotherapeutics for Cancer Treatments
    Tao Wang et al, 2020, Nanotechnology in Regenerative Medicine and Drug Delivery Therapy CrossRef
  3. Properties of realgar bioleaching using an extremely acidophilic bacterium and its antitumor mechanism as an anticancer agent
    Peng Chen et al, 2017, Biological Research CrossRef
  4. Mineral medicine: from traditional drugs to multifunctional delivery systems
    Xiaoqing Zhong et al, 2022, Chinese Medicine CrossRef
  5. Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer
    Peng Song et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef
  6. Long non-coding RNA ROR confers arsenic trioxide resistance to HepG2 cells by inhibiting p53 expression
    Xinyang Li et al, 2020, European Journal of Pharmacology CrossRef
  7. The in vivo process of realgar from absorption to excretion
    Yan Luo et al, 2023, Pharmacological Research - Modern Chinese Medicine CrossRef
  8. Arsenic disulfide‑induced apoptosis and its potential mechanism in two‑ and three‑dimensionally cultured human breast cancer MCF‑7 cells
    Yuxue Zhao et al, 2018, International Journal of Oncology CrossRef
  9. Acid Water-ground Nano-realgar Is Superior to Crude Realgar in Promoting Apoptosis of MCF-7 Breast Cancer Cells
    Juan Xi et al, 2022, Current Medical Science CrossRef
  10. Toxic effects of realgar transforming solution on the reproduction of Caenorhabditis elegans
    Dongling Liu et al, 2018, Toxicological & Environmental Chemistry CrossRef
  11. Autophagy enhanced antitumor effect in K562 and K562/ADM cells using realgar transforming solution
    Xin Wang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  12. Pharmacology, Toxicology, and Rational Application of Cinnabar, Realgar, and Their Formulations
    Huifang Guan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  13. Xanthine oxidase, a therapeutic target of realgar for non-small cell lung cancer
    Rui Guo et al, 2023, Heliyon CrossRef
  14. Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML/RARα partially through the ubiquitin–proteasome pathway
    Yang Hai et al, 2019, Archives of Pharmacal Research CrossRef
  15. Realgar transforming solution as a novel arsenic agent with a lower risk of cardiotoxicity
    Yang Hai et al, 2019, Journal of Pharmacological Sciences CrossRef
  16. Realgar transforming solution suppresses angiogenesis and tumor growth by inhibiting VEGF receptor 2 signaling in vein endothelial cells
    Peng Song et al, 2018, Archives of Pharmacal Research CrossRef
  17. What Chinese Medicine Can Do for Liver Cancer?
    Feiyu Chen et al, 2018, Liver Cancer CrossRef
  18. Use of LSPR Spectroscopy Biosensing for In Situ Identification of Arsenic from Bioleaching of Realgar by Acidithiobacillus ferrooxidans
    Ruixiang Xu et al, 2018, Journal of Spectroscopy CrossRef
  19. Realgar toxicity in terms of its chemical characterization, pharmacological mechanisms, and metabolic profile: A review
    Yan Yi et al, 2023, Science of Traditional Chinese Medicine CrossRef